Lactoferrin: A roadmap to the borderland between caries and periodontal disease

Journal of Dental Research

Volumn 94, Issue 6, 2015, Pages 768-776

  Fine, D H ^a  

^a RUTGERS SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

aggressive periodontitis; dental caries; ecosystem; saliva; single nucleotide polymorphisms; streptococcus mutans

Indexed keywords

ANTIINFECTIVE AGENT; LACTOFERRIN; LTF PROTEIN, HUMAN; LYSINE;

AGGRESSIVE PERIODONTITIS; BIOFILM; DENTAL CARIES; DRUG EFFECTS; GENETICS; HUMAN; MICROBIOLOGY; PHYSIOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; STREPTOCOCCUS MUTANS; TOOTH PLAQUE;

AGGRESSIVE PERIODONTITIS; ANTI-INFECTIVE AGENTS; BIOFILMS; DENTAL CARIES; DENTAL PLAQUE; HUMANS; LACTOFERRIN; LYSINE; POLYMORPHISM, SINGLE NUCLEOTIDE; STREPTOCOCCUS MUTANS;

EID: 84930463280     PISSN: 00220345     EISSN: 15440591     Source Type: Journal    
DOI: 10.1177/0022034515577413     Document Type: Article

References (60)

1. Abreu MT, Vora P, Faure E, Thomas LS, Arnold ET, Arditi M. Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. J Immunol.. 2001 ; 167 (3). 1609-1616
2. Actor JK, Hwang SA, Kruzel ML. Lactoferrin as a natural immune modulator. Curr Pharm Des.. 2009 ; 15 (17). 1956-1973
3. Adonogianaki E, Moughal NA, Kinane DF. Lactoferrin in the gingival crevice as a marker of polymorphonuclear leucocytes in periodontal diseases. J Clin Periodontol.. 1993 ; 20 (1). 26-31
4. Alugupalli KR, Kalfas S. Inhibitory effect of lactoferrin on the adhesion of Actinobacillus actinomycetemcomitans and Prevotella intermedia to fibroblasts and epithelial cells. APMIS.. 1995 ; 103 (2). 154-160
5. Anderson LC, Lamberts BL, Bruton WF. Salivary protein polymorphisms in caries-free and caries-active adults. J Dent Res.. 1982 ; 61 (2). 393-396
6. Appelmelk BJ, An YQ, Geerts M, Thijs BG, de Boer HA, MacLaren DM, de Graaff J, Nuijens JH. Lactoferrin is a lipid A-binding protein. Infect Immun.. 1994 ; 62 (6). 2628-2632
7. Arnold RR, Cole MF, McGhee JR. A bactericidal effect for human lactoferrin. Science.. 1977 ; 197 (4300). 263-265
8. Arnold RR, Russell JE, Champion WJ, Gauthier JJ. Bactericidal activity of human lactoferrin: influence of physical conditions and metabolic state of the target microorganism. Infect Immun.. 1981 ; 32 (2). 655-660
9. Azevedo LF, Pecharki GD, Brancher JA, Cordeiro CA, Medeiros KG, Antunes AA, Arruda ES, Werneck RI, de Azevedo LR, Mazur RF, et al. Analysis of the association between lactotransferrin (LTF) gene polymorphism and dental caries. J Appl Oral Sci.. 2010 ; 18 (2). 166-170
10. Baker EN, Baker HM. A structural framework for understanding the multifunctional character of lactoferrin. Biochimie.. 2009 ; 91 (1). 3-10
11. Baveye S, Elass E, Fernig DG, Blanquart C, Mazurier J, Legrand D. Human lactoferrin interacts with soluble CD14 and inhibits expression of endothelial adhesion molecules, E-selectin and ICAM-1, induced by the CD14-lipopolysaccharide complex. Infect Immun.. 2000 ; 68 (12). 6519-6525
12. Curtis MA, Zenobia C, Darveau RP. The relationship of the oral microbiotia to periodontal health and disease. Cell Host Microbe.. 2011 ; 10 (4). 302-326
13. Dreizen S, Brown LR. Xerostomia and dental caries. Microbial aspects of dental caries: proceedings of a workshop on microbial aspects of dental caries ; 1976 St Simons Island, Georgia ; 1976. 263.
14. Elass-Rochard E, Roseanu A, Legrand D, Trif M, Salmon V, Motas C, Montreuil J, Spik G. Lactoferrin-lipopolysaccharide interaction: involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli 055B5 lipopolysaccharide. Biochem J.. 1995 ; 312 (Pt 3). 839-845
15. Farnaud S, Evans RW. Lactoferrin: a multifunctional protein with antimicrobial properties. Mol Immunol.. 2003 ; 40 (7). 395-405
16. Fine DH, Furgang D. Lactoferrin iron levels affect attachment of Actinobacillus actinomycetemcomitans to buccal epithelial cells. J Periodontol.. 2002 ; 73 (6). 616-623
17. Fine DH, Furgang D, Beydouin F. Lactoferrin iron levels are reduced in saliva of patients with localized aggressive periodontitis. J Periodontol.. 2002 ; 73 (6). 624-630
18. Fine DH, Furgang D, Goldman D. Saliva from subjects harboring Actinobacillus actinomycetemcomitans kills Streptococcus mutans in vitro. J Periodontol.. 2007 ; 78 (3). 518-526
19. Fine DH, Furgang D, McKiernan M, Rubin M. Can salivary activity predict periodontal breakdown in A. actinomycetemcomitans infected adolescents?. Arch Oral Biol.. 2013 ; 58 (6). 611-620
20. Fine DH, Goldberg D, Karol R. Caries levels in patients with juvenile periodontitis. J Periodontol.. 1984 ; 55 (4). 242-246
21. Fine DH, Toruner GA, Velliyagounder K, Sampathkumar V, Godboley D, Furgang D. A lactotransferrin single nucleotide polymorphism demonstrates biological activity that can reduce susceptibility to caries. Infect Immun.. 2013 ; 81 (5). 1596-15605
22. Friedman SA, Mandel ID, Herrera MS. Lysozyme and lactoferrin quantitation in the crevicular fluid. J Periodontol.. 1983 ; 54 (6). 347-350
23. Glimvall P, Wickstrom C, Jansson H. Elevated levels of salivary lactoferrin, a marker for chronic periodontitis?. J Periodontal Res.. 2012 ; 47 (5). 655-660
24. Gorr SU, Abdolhosseini M. Antimicrobial peptides and periodontal disease. J Clin Periodontol. 2011 ; 38: 126-141
25. Griffen AL, Beall CJ, Campbell JH, Firestone ND, Kumar PS, Yang ZK, Podar M, Leys EJ. Distinct and complex bacterial profiles in human periodontitis and health revealed by 16S pyrosequencing. ISME J.. 2012 ; 6 (6). 1176-1185
26. Gross EL, Beall CJ, Kutsch SR, Firestone ND, Leys EJ, Griffen AL. Beyond Streptococcus mutans: dental caries onset linked to multiple species by 16S rRNA community analysis. PloS One. 2012 ; 7 (10). e47722
27. Guillen C, McInnes IB, Vaughan D, Speekenbrink AB, Brock JH. The effects of local administration of lactoferrin on inflammation in murine autoimmune and infectious arthritis. Arthritis Rheum.. 2000 ; 43 (9). 2073-2080
28. Hajishengallis G. Immunomicrobial pathogenesis of periodontitis: keystones, pathobionts, and host response. Trends Immunol.. 2014 ; 35 (1). 3-11
29. Haubek D, Johansson A. Pathogenicity of the highly leukotoxic JP2 clone of Aggregatibacter actinomycetemcomitans and its geographic dissemination and role in aggressive periodontitis. J Oral Microbiol. 2014 ;:
30. Helmerhorst EJ, Oppenheim FG. Saliva: a dynamic proteome. J Dent Res.. 2007 ; 86 (8). 680-693
31. Hooper LV. Do symbiotic bacteria subvert host immunity?. Nat Rev Microbiol.. 2009 ; 7 (5). 367-374
32. Jordan WJ, Eskdale J, Lennon GP, Pestoff R, Wu L, Fine DH, Gallagher G. A non-conservative, coding single-nucleotide polymorphism in the N-terminal region of lactoferrin is associated with aggressive periodontitis in an African-American, but not a Caucasian population. Genes Immun.. 2005 ; 6 (7). 632-635
33. Kawai T, Akira S. Pathogen recognition with Toll-like receptors. Curr Opin Immunol.. 2005 ; 17 (4). 338-344
34. Keijser S, Jager MJ, Dogterom-Ballering HC, Schoonderwoerd DT, de Keizer RJ, Krose CJ, Houwing-Duistermaat JJ, van der Plas MJ, van Dissel JT, Nibbering PH. Lactoferrin Glu561Asp polymorphism is associated with susceptibility to herpes simplex keratitis. Exp Eye Res.. 2008 ; 86 (1). 105-109
35. Legrand D, Elass E, Carpentier M, Mazurier J. Lactoferrin: a modulator of immune and inflammatory responses. Cell Mol Life Sci.. 2005 ; 62 (22). 2549-2559
36. Legrand D, Elass E, Carpentier M, Mazurier J. Interactions of lactoferrin with cells involved in immune function. Biochem Cell Bio.. 2006 ; 84 (3). 282-290
37. Mandel ID. The functions of saliva. J Dent Res.. 1987 ; 66: 623-627
38. Marsh PD. Are dental diseases examples of ecological catastrophes?. Microbiol.. 2003 ; 149 (Pt 2). 279-294
39. Marsh PD, Devine DA. How is the development of dental biofilms influenced by the host?. J Clin Periodontol.. 2011 ; 38: 28-35
40. Miyake K. Innate recognition of lipopolysaccharide by Toll-like receptor 4-MD-2. Trends Microbiol.. 2004 ; 12 (4). 186-192
41. Mohamed JA, DuPont HL, Flores J, Palur H, Nair P, Jiang ZD, Guo D, Belkind-Gerson J, Okhuysen PC. Single nucleotide polymorphisms in the promoter of the gene encoding the lipopolysaccharide receptor CD14 are associated with bacterial diarrhea in US and Canadian travelers to Mexico. Clin Infect Dis.. 2011 ; 52 (11). 1332-1341
42. Mohamed JA, DuPont HL, Jiang ZD, Belkind-Gerson J, Figueroa JF, Armitige LY, Tsai A, Nair P, Martinez-Sandoval FJ, Guo DC, et al. A novel single-nucleotide polymorphism in the lactoferrin gene is associated with susceptibility to diarrhea in North American travelers to Mexico. Clin Infect Dis.. 2007 ; 44 (7). 945-952
43. Naidu SS, Svensson U, Kishore AR, Naidu AS. Relationship between antibacterial activity and porin binding of lactoferrin in Escherichia coli and Salmonella typhimurium. Antimicrob Agents Chemother. 1993 ; 37 (2). 240-245
44. Nibali L, Henderson B, Sadiq ST, Donos N. Genetic dysbiosis: the role of microbial insults in chronic inflammatory diseases. J Oral Microbiol.. 2014 ;:
45. Nibbering PH, Ravensbergen E, Welling MM, van Berkel LA, van Berkel PH, Pauwels EK, Nuijens JH. Human lactoferrin and peptides derived from its N terminus are highly effective against infections with antibiotic-resistant bacteria. Infect Immun.. 2001 ; 69 (3). 1469-1476
46. Odell EW, Sarra R, Foxworthy M, Chapple DS, Evans RW. Antibacterial activity of peptides homologous to a loop region in human lactoferrin. FEBS Lett.. 1996 ; 382 (1-2). 175-178
47. Oppenheim FG, Salih E, Siqueira WL, Zhang W, Helmerhorst EJ. Salivary proteome and its genetic polymorphisms. Ann NY Acad of Sci.. 2007 ; 1098: 22-50
48. Ren L, Leung WK, Darveau RP, Jin L. The expression profile of lipopolysaccharide-binding protein, membrane-bound CD14, and toll-like receptors 2 and 4 in chronic periodontitis. J Periodontol.. 2005 ; 76 (11). 1950-1959
49. Rosenfeld Y, Papo N, Shai Y. Endotoxin (lipopolysaccharide) neutralization by innate immunity host-defense peptides. J Biol Chem.. 2006 ; 281 (3). 1636-1643
50. Rudney JD, Hickey KL, Ji Z. Cumulative correlations of lysozyme, lactoferrin, peroxidase, S-IgA, amylase, and total protein concentrations with adherence of oral viridans streptococci to microplates coated with human saliva. J Dent Res.. 1999 ; 78 (3). 759-768
51. Scannapieco FA. Saliva-bacterium interactions in oral microbial ecology. Crit Rev Oral Biol Med. 1994 ; 5 (3-4). 203-248
52. Scott MG, Vreugdenhil AC, Buurman MA, Hancock RE, Gold MR. Cutting edge: cationic antimicrobial peptides block the binding of lipopolysaccharide (LPS) to LPS binding protein. J Immunol.. 2000 ; 164 (2). 549-553
53. Sidhu R, Wilson P, Wright A, Yau CW, D'Cruz FA, Foye L, Morley S, Lobo AJ, McAlindon ME, Sanders DS. Faecal lactoferrin: a novel test to differentiate between the irritable and inflamed bowel?. Aliment Pharmacol Ther.. 2010 ; 31 (12). 1365-1370
54. Sikorska MH, Mielnik-Blaszczak M, Kapea E. The relationship between the levels of SigA, lactoferrin and alpha(1) proteinase inhibitor in saliva and permanent dentition caries in 15-year-olds. Oral Microbiol Immunol.. 2002 ; 17 (5). 272-276
55. Singh PK, Parsek MR, Greenberg EP, Welsh MJ. A component of innate immunity prevents bacterial biofilm development. Nature.. 2002 ; 417 (6888). 552-555
56. Velliyagounder K, Kaplan JB, Furgang D, Legarda D, Diamond G, Parkin RE, Fine DH. One of two human lactoferrin variants exhibits increased antibacterial and transcriptional activation activities and is associated with localized juvenile periodontitis. Infect Immun.. 2003 ; 71 (11). 6141-6147
57. Velusamy SK, Ganeshnarayan K, Markowitz K, Schreiner H, Furgang D, Fine DH, Velliyagounder K. Lactoferrin knockout mice demonstrates greater susceptibility to Aggregatibacter actinomycetemcomitans-induced periodontal disease. J Periodontol.. 2013 ; 84 (11). 1690-1701
58. Visintin A, Iliev DB, Monks BG, Halmen KA, Golenbock DT. MD-2. Immunobiology. 2006 ; 211 (6-8). 437-447
59. Wu YM, Juo SH, Ho YP, Ho KY, Yang YH, Tsai CC. Association between lactoferrin gene polymorphisms and aggressive periodontitis among Taiwanese patients. J Periodontal Res.. 2009 ; 44 (3). 418-424
60. Wurfel MM, Hailman E, Wright SD. Soluble CD14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high density lipoprotein. J Exp Med.. 1995 ; 181 (5). 1743-1754